![](/img/cover-not-exists.png)
Best Practices for Communication between FDA and Applicants during the NDA Review Cycle: A PhRMA White Paper
Cocchetto, D. M., Stotka, J. L., Zezza, D., Hassall, T. H., Brophy, G., Peterson, D.Volume:
42
Language:
english
Journal:
Therapeutic Innovation & Regulatory Science
DOI:
10.1177/009286150804200102
Date:
January, 2008
File:
PDF, 6.26 MB
english, 2008